Acland et al performed successful RPE65 gene replacement therapy in natural canine models of LCA that resulted in restoration of vision, a landmark experiment that prompted clinical scientists to adopt the strategy to restore vision in humans with recessive retinal degenerative diseases.[3]. This evidence concerns the gene RPE65 and Leber congenital amaurosis.